Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Menorrhagia × relugolix × Clear all

Phase

Status

Completed 2 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 12 Leiomyoma 4 Prostate Adenocarcinoma 2 Myofibroma 2 Endometriosis 2 Uterine Neoplasms 1 Uterine Hemorrhage 1 Pregnancy Complications 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Myoma 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Menorrhagia 1 Adenocarcinoma 1

Interventions

relugolix 1 Uterine Myomectomy 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡